stoxline Quote Chart Rank Option Currency Glossary
  
Neptune Wellness Solutions Inc. (NEPT)
0.2  0 (0%)    06-04 16:00
Open: 0.25
High: 0.25
Volume: 2,226,075
  
Pre. Close: 0.2
Low: 0.2
Market Cap: 1(M)
Technical analysis
2024-05-31 4:54:31 PM
Short term     
Mid term     
Targets 6-month :  0.29 1-year :  0.34
Resists First :  0.25 Second :  0.29
Pivot price 0.07
Supports First :  0.11 Second :  0.02
MAs MA(5) :  0.07 MA(20) :  0.08
MA(100) :  0.3 MA(250) :  2.85
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  28.2 D(3) :  11.3
RSI RSI(14): 67
52-week High :  25.59 Low :  0.02
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ NEPT ] has closed above the upper band by 28.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 26.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.25 - 0.25 0.25 - 0.25
Low: 0.2 - 0.2 0.2 - 0.2
Close: 0.2 - 0.2 0.2 - 0.2
Company Description

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

Headline News

Thu, 13 Jun 2024
Newsflash: Neptune Wellness Solutions Inc. (TSE:NEPT) Analysts Have Been Trimming Their Revenue Forecasts - Yahoo New Zealand News

Tue, 30 Apr 2024
Neptune Wellness Solutions insider sells shares worth over $21k By Investing.com - Investing.com

Wed, 06 Mar 2024
Neptune Wellness to be delisted from Nasdaq By Investing.com - Investing.com

Wed, 06 Mar 2024
Neptune Wellness Faces Nasdaq Delisting, Considers OTCQB Move - TipRanks.com - TipRanks

Tue, 27 Feb 2024
Neptune Wellness Executives on Unpaid Leave Amid Restructuring - TipRanks.com - TipRanks

Tue, 05 Dec 2023
Neptune Wellness shares said to get delisted from Nasdaq (NASDAQ:NEPT) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 5 (M)
Shares Float 3 (M)
Held by Insiders 43.7 (%)
Held by Institutions 6 (%)
Shares Short 25 (K)
Shares Short P.Month 7 (K)
Stock Financials
EPS -200.2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -6.89
Profit Margin -136.9 %
Operating Margin -232.9 %
Return on Assets (ttm) -67 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -37.8 %
Gross Profit (p.s.) 0
Sales Per Share 8.63
EBITDA (p.s.) -9.97
Qtrly Earnings Growth 0 %
Operating Cash Flow -15 (M)
Levered Free Cash Flow -2 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value -0.03
Price to Sales 0.02
Price to Cash Flow -0.06
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android